Instrumentation for optical monitoring of apoptosis in unlabeled cell cultures

用于光学监测未标记细胞培养物中细胞凋亡的仪器

基本信息

项目摘要

DESCRIPTION (provided by applicant): Apoptosis, "programmed cell death," is a cellular process exhibiting distinct biochemical and morphological changes, and is a key element of both normal and disease processes at the cellular level. As such, apoptosis is the subject of thousands of publications annually, yet none of the assays that are commonly used to detect or track apoptosis are performed on viable cells, as all require disruption of cultures or tissue, often by fixation and staining. A nondisruptive assay of apoptosis would enable real-time monitoring of cells and cell cultures, dramatically facilitating such studies, and generally eliminating standard labor-intensive assays. Additional impact would obtain if the method could expose and identify specific apoptotic pathways. Moreover, since massive apoptosis is one of the earliest indications of response to most types of anti-cancer treatment, a longer-term (after this project) in-vivo application of a noninvasive assay could impact management of cancer treatment. Elastic scattering spectroscopy (ESS) is a noninvasive, real-time, optical method that uses light scattering measurements to obtain quantitative information about the micromorphology of cells and tissue. This project will develop and test novel instrumentation that uses ESS and is specifically designed to realize nondisruptive, quantitative monitoring of apoptosis in viable cell cultures in real time, for both plated cultures and cell suspensions. This will be effected by measuring the wavelength-dependence (spectrum) of scattered light at selected angles, and the angle-dependence (phase function) of scattered light at specific wavelengths, from individual cells or ensembles of cells in culture, either in suspension or in conventional culture plates. The spectral ESS system will incorporate a specialized "mini-incubator" optical chamber to maintain cells during a sequence of measurements. For measurement of the angular scattering phase function, our novel polar nephelometer will be adapted to facilitate measurements on plated cultures. Since individual measurements are nearly instantaneous, the ESS method will enable the tracking of changes in micromorphology over any desired time span. Analytical and computational methods will be used, applied to the resulting spectra and angle measurements, to extract the size distributions of scatterers within the cells, thus providing quantitative measures related to cellular ultrastructure. Extensive validations will be performed using established biochemical assays that are well understood, as well as environmental scanning electron microscopy. PUBLIC HEALTH RELEVANCE: In studying disease processes and the response of cells to treatments, it is critical to monitor and understand the mechanisms of cell death. The proposed instrumentation will enable cellular biologists, who are studying cellular response to treatment, to monitor and evaluate cell-death processes in a faster and less labor-intensive manner, by using light-based measurements instead of the current chemical assays.
描述(由申请人提供):凋亡,“程序性细胞死亡”,是一种细胞过程,表现出不同的生化和形态变化,是细胞水平正常和疾病过程的关键要素。因此,凋亡是每年数千个出版物的主题,但是通常没有用于检测或轨道凋亡的通常在可行细胞上进行凋亡,因为所有测定方法通常都需要破坏培养物或组织,通常是通过固定和染色来进行培养或组织。凋亡的非干扰性测定将使细胞和细胞培养物进行实时监测,极大地促进此类研究,并通常消除标准的劳动密集型测定法。如果该方法可以暴露并识别特定的凋亡途径,将获得其他影响。此外,由于大规模凋亡是对大多数抗癌治疗的反应的最早迹象之一,因此长期(在该项目之后)对非侵入性测定的应用可能会影响癌症治疗的管理。弹性散射光谱(ESS)是一种无创,实时的光学方法,它使用光散射测量来获取有关细胞和组织的微观形态学的定量信息。该项目将开发和测试使用ESS的新型仪器,并专门设计用于实时实时对可行细胞培养物中细胞凋亡的非干扰性监测,用于板条培养物和细胞悬浮液。这将通过在选定角度测量散射光的波长依赖性(光谱)以及在悬浮液或常规培养平板中的单个细胞或培养物中的单个细胞或培养物中的散射光的角度依赖性(相位函数)。光谱ESS系统将在一系列测量过程中结合一个专门的“迷你启动器”光学室,以维持细胞。为了测量角散射相函数,我们的新型极性肾上腺计将适应以促进对板培养物的测量。由于单个测量值几乎是瞬时的,因此ESS方法将在任何所需的时间范围内跟踪微观形态的变化。将使用分析方法和计算方法,应用于所得的光谱和角度测量值,以提取细胞内散射器的尺寸分布,从而提供与细胞超微结构有关的定量测量。将使用已确定的生化测定法以及环境扫描电子显微镜进行广泛的验证。公共卫生相关性:在研究疾病过程和细胞对治疗的反应时,监测和了解细胞死亡的机制至关重要。所提出的仪器将通过使用基于光基测量值而不是当前的化学分析,以研究细胞反应的细胞生物学家,以更快,更少的劳动密集型方式来监测和评估细胞死亡过程。

项目成果

期刊论文数量(2)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

IRVING J. BIGIO其他文献

IRVING J. BIGIO的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('IRVING J. BIGIO', 18)}}的其他基金

Optimization and validation of quantitative birefringence microscopy for assessment of myelin pathologies associated with cognitive impairments and motor deficits in young and old aging monkey brain
定量双折射显微镜的优化和验证,用于评估与年轻和年老猴脑认知障碍和运动缺陷相关的髓磷脂病理学
  • 批准号:
    10544518
  • 财政年份:
    2022
  • 资助金额:
    $ 20.31万
  • 项目类别:
Optimization and validation of quantitative birefringence microscopy for assessment of myelin pathologies associated with cognitive impairments and motor deficits in young and old aging monkey brain
定量双折射显微镜的优化和验证,用于评估与年轻和年老猴脑认知障碍和运动缺陷相关的髓磷脂病理学
  • 批准号:
    10369974
  • 财政年份:
    2022
  • 资助金额:
    $ 20.31万
  • 项目类别:
Instrumentation for optical monitoring of apoptosis in unlabeled cell cultures
用于光学监测未标记细胞培养物中细胞凋亡的仪器
  • 批准号:
    7740280
  • 财政年份:
    2009
  • 资助金额:
    $ 20.31万
  • 项目类别:
Optic Imaging of Fast Neural Activation Patterns in Brain Tissue
脑组织中快速神经激活模式的光学成像
  • 批准号:
    7467221
  • 财政年份:
    2007
  • 资助金额:
    $ 20.31万
  • 项目类别:
Optic Imaging of Fast Neural Activation Patterns in Brain Tissue
脑组织中快速神经激活模式的光学成像
  • 批准号:
    7293164
  • 财政年份:
    2007
  • 资助金额:
    $ 20.31万
  • 项目类别:
Optical Spectroscopy for Management of Cancer Treatment
光谱用于癌症治疗管理
  • 批准号:
    6949079
  • 财政年份:
    2003
  • 资助金额:
    $ 20.31万
  • 项目类别:
Optical Spectroscopy for Management of Cancer Treatment
光谱用于癌症治疗管理
  • 批准号:
    6807007
  • 财政年份:
    2003
  • 资助金额:
    $ 20.31万
  • 项目类别:
Optical Spectroscopy for Management of Cancer Treatment
光谱用于癌症治疗管理
  • 批准号:
    6712390
  • 财政年份:
    2003
  • 资助金额:
    $ 20.31万
  • 项目类别:
Optical Spectroscopy for Management of Cancer Treatment
光谱用于癌症治疗管理
  • 批准号:
    7284200
  • 财政年份:
    2003
  • 资助金额:
    $ 20.31万
  • 项目类别:
Optical Spectroscopy for Management of Cancer Treatment
光谱用于癌症治疗管理
  • 批准号:
    7124693
  • 财政年份:
    2003
  • 资助金额:
    $ 20.31万
  • 项目类别:

相似国自然基金

基于巨噬细胞表型转变探讨BTSA1诱导衰老肌成纤维细胞凋亡及促肺纤维化消退的机制
  • 批准号:
    82370077
  • 批准年份:
    2023
  • 资助金额:
    49 万元
  • 项目类别:
    面上项目
STAB1调控Fas/FasL介导牦牛胎盘滋养层细胞凋亡及胎盘炎症性流产的作用与机制研究
  • 批准号:
    32360836
  • 批准年份:
    2023
  • 资助金额:
    32 万元
  • 项目类别:
    地区科学基金项目
ATAD3A琥珀酰化调控mtDNA损伤-泛凋亡反应轴在心梗后心衰中的作用研究
  • 批准号:
    82300434
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
胸腺肽α-1介导凋亡小体RNA改善DC功能增强TNBC化疗后抗肿瘤免疫应答的机制研究
  • 批准号:
    82303959
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
LSD1通过使组蛋白H3K4位点去甲基化促进自噬参与肾小管上皮细胞凋亡和肾脏纤维化的机制研究
  • 批准号:
    82300769
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

Evaluating the efficacy of Butyric acid pro-drug nanoparticle in retinal neuroprotection
评估丁酸前药纳米颗粒在视网膜神经保护中的功效
  • 批准号:
    10602346
  • 财政年份:
    2023
  • 资助金额:
    $ 20.31万
  • 项目类别:
Biochemical Mechanisms for Sustained Humoral Immunity
持续体液免疫的生化机制
  • 批准号:
    10637251
  • 财政年份:
    2023
  • 资助金额:
    $ 20.31万
  • 项目类别:
Oxidative Lipidomics in Pediatric Traumatic Brain Injury
氧化脂质组学在小儿创伤性脑损伤中的应用
  • 批准号:
    10844023
  • 财政年份:
    2023
  • 资助金额:
    $ 20.31万
  • 项目类别:
Enhancing chemotherapeutic efficacy in triple-negative breast cancer via DSTYK silence
通过 DSTYK 沉默增强三阴性乳腺癌的化疗效果
  • 批准号:
    10657021
  • 财政年份:
    2023
  • 资助金额:
    $ 20.31万
  • 项目类别:
Development of caspase-6 inhibitors for treatment of NASH
开发治疗 NASH 的 caspase-6 抑制剂
  • 批准号:
    10608905
  • 财政年份:
    2023
  • 资助金额:
    $ 20.31万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了